At Extreme Investor Network, we strive to provide unique and valuable insights into the world of investing. Today, we are excited to discuss the innovative use of AI technology in stock picking and how it can benefit individual investors.
IFi AI is a cutting-edge company that leverages machine learning to identify stocks with potential upside. Their model combines fundamental, technical, and news data to make informed predictions about stock performance. Powered by IBM’s Watsonx, IFi AI’s AI model has already proven its accuracy with successful calls, such as Marathon Oil’s recent acquisition by ConocoPhillips.
One of the standout stocks in IFi AI’s radar is Marathon Digital, a bitcoin mining company. Despite a decline in 2024, IFi AI predicts a significant 40% jump in Marathon Digital’s stock price in the next month. Additionally, Kilroy Realty, a real estate investment trust, has caught IFi AI’s attention with its potential for growth, especially in the current uncertain office real estate market.
In the biotech sector, IFi AI has identified three promising stocks with high confidence and big upside potential: BridgeBio Pharma, Viking Therapeutics, and Protagonist Therapeutics. These companies operate in a volatile industry where a single drug update can affect their stock performance significantly.
Led by CNBC senior analyst Ron Insana, IFi AI is pioneering the use of AI technology in stock picking for individual investors. With a track record of success and a focus on high-potential stocks, IFi AI is a valuable resource for those looking to make informed investment decisions.
Stay tuned to Extreme Investor Network for more exclusive insights and investment opportunities in the ever-evolving world of finance.